Prestige Consumer Healthcare Inc
7 nominees · 3 ballot items.
Election of seven board nominees, advisory vote on named executive officer compensation, and ratification of independent auditor at Prestige's 2025 Annual Meeting.
Follow how the vote landed and what changed on Prestige Consumer Healthcare Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of the seven directors nominated by the Board of Directors and named in this Proxy Statement to serve until the 2026 Annual Meeting of Stockholders or until their earlier death, removal or resignation
ManagementBoard: FORElection of seven board nominees to serve until the 2026 annual meeting and until their successors are elected and qualified.
- 2
Advisory Vote to Approve Named Executive Officer Compensation
ManagementBoard: FORNon-binding vote to approve the compensation of Prestige's named executive officers as disclosed in the proxy statement.
- 3
Ratification of the Appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm
ManagementBoard: FORRatify the appointment of PricewaterhouseCoopers LLP as Prestige's independent registered public accounting firm for the fiscal year ending March 31, 2026.
Nominees on the ballot7
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11.0% | 5,191,569 | $308M |
| 2 | ARIEL INVESTMENTS, LLC | 8.6% | 4,092,721 | $243M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.9% | 2,803,828 | $166M |
| 4 | DIMENSIONAL FUND ADVISORS LP | 5.4% | 2,562,460 | $152M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 2,092,993 | $124M |
| 6 | STATE STREET CORP | 4.2% | 1,970,981 | $117M |
| 7 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 3.7% | 1,744,694 | $103M |
| 8 | Allspring Global Investments Holdings, LLC | 3.3% | 1,557,296 | $90M |
| 9 | BlackRock, Inc. | 3.0% | 1,437,629 | $85M |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.7% | 1,291,278 | $77M |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Prestige Consumer Healthcare Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Prestige Consumer Healthcare Inc 2025 annual meeting?
- Prestige Consumer Healthcare Inc (PBH) holds its 2025 annual shareholder meeting on Tuesday, August 5, 2025.
- What is the record date for the Prestige Consumer Healthcare Inc 2025 meeting?
- The record date for the Prestige Consumer Healthcare Inc 2025 meeting is Tuesday, June 10, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Prestige Consumer Healthcare Inc's 2025 meeting?
- The board is presenting 7 director nominees at the Prestige Consumer Healthcare Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Prestige Consumer Healthcare Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Prestige Consumer Healthcare Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.